(University of Cincinnati Academic Health Center) A researcher in the University of Cincinnati (UC) College of Medicine has been granted a US patent for a potential treatment for a pulmonary infection in patients with cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD).The treatment, known as AB569, was developed in the lab of Daniel Hassett, PhD, a professor in the UC Department of Molecular Genetics, Biochemistry and Microbiology.
from EurekAlert! - Social and Behavioral Science https://ift.tt/CORih4
No comments:
Post a Comment